



An ti-Mülle rian hor mo ne (AMH) is a glycop ro tein be lon gi ng to the tran sfor mi ng growth fac to rs (TGF-β). AMH plays a fun da men tal ro le in the reg-
res sion of Mülle rian duc ts in ma le em bryo. In its ab sen ce, Mülle rian duc ts de ve lop in to fe ma le in ner rep ro duc ti ve or ga ns. In boys, it is sig ni fi  can tly 
pro du ced in Ser to li cel ls of tes tes un til pu ber ty and then slowly dec rea ses to re si dual va lues for the re st of the me n’s li fe. AMH ser ves as a bioc he mi-
cal mar ker of the pre sen ce of tes tes in cryptor chi dic ma les. In fe ma les, AMH is sec re ted by gra nu lo sa cel ls of sma ll fol lic les in the ova ry. Se rum va lues 
are al mo st un de tec tab le du ri ng in fan cy and then ra pid ly in crea se wi th the on set of pu ber ty, refl ec ti ng the ini tial rec ruit me nt of pri mor dial fol lic les. 
AMH is pro du ced in growi ng fol lic les un til they rea ch a sta ge when do mi na nt fol lic le is de tac hed from a co ho rt of an tral fol lic les. The mea su re me nt 
of se rum AMH le ve ls du ri ng wo ma n’s rep ro duc ti ve li fe rep re sen ts an ideal tool for the as ses sme nt of the ova rian fol li cu lar re ser ve. The ad van ta ge of 
AMH in re la tion to the ova rian ste roid hor mo nes is that se rum le ve ls do not fl uc tua te sig ni fi  can tly du ri ng the men strual cycle. In ad di tion, cir cu la ti-
ng AMH stron gly cor re la tes wi th an tral fol lic le cou nt (AFC), vi sua li zed by ul tra sou nd in the fol li cu lar pha se of the cycle. As the num ber and qua li ty of 
the oo cytes di mi ni sh throug hout the wo ma n’s rep ro duc ti ve li fe, se rum con cen tra tio ns of AMH gra dual ly dec rea se and fa ll be low de tec tab le le ve ls 
in me no pau se. This cou ld be of par ti cu lar in te re st in sub fer ti le and in fer ti le wo men un der goi ng as sis ted rep ro duc ti ve tec hniques (ART) in ac hie vi ng 
preg nan cy.
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Review
In tro duc tion
An ti-Mülle rian hor mo ne (AMH) is a 140-kDa di me-
ric glycop ro tein hor mo ne and be lon gs to the tran-
sfor mi ng growth fac to r-β (TGF-β) fa mi ly. AMH is 
synthe si zed as a lar ge pre cur sor wi th a sho rt sig nal 
sequen ce fol lowed by the pre-pro hor mo ne that 
for ms ho mo di me rs. Prior to sec re tion, the ma tu re 
hor mo ne un der goes glyco syla tion and di me ri za-
tion to pro du ce a 144-kDa di mer com po sed of 
iden ti cal di sul phi de-lin ked 72-kDa mo no mer su-
bu ni ts. Ea ch mo no mer con tai ns an N-ter mi nal do-
main (al so cal led the “pro re gio n”) and a C-ter mi-
nal do main (al so cal led the “ma tu re re gio n”); it is 
be lie ved that N-ter mi nal do main ac cen tua tes the 
ac ti vi ty of the C-ter mi nal do main in whi ch re si des 
the bioac ti vi ty of the mo le cu le (1). Du ri ng cytop-
las mic tran sit, be tween 5 and 20% of AMH is clea-
ved at a spe ci fi c si te be tween the N-ter mi nal and 
the C-ter mi nal do main of the 72-kDa mo no mer, to 
fo rm two po lypep ti des of 58-kDa (pro re gion) and 
12-kDa (ma tu re re gion). The se two par ts of the 
mo le cu le re main in non co va le nt at tac hme nt. The 
hu man ge ne co di ng for AMH is lo ca ted on the 
sho rt arm of chro mo so me 19; it has been sequen-
ced and iso la ted (2).
AMH sig na li ng pat hway
Tar get or ga ns for AMH in ma les are Mülle rian duc-
ts and, in bo th sexes, go na ds. The struc tu re of the 
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spe ci fi c re cep tor for AMH has been iso la ted and 
cha rac te ri zed (3). As a mem ber of the TGFβ fa mi ly 
of growth fac to rs, it is thoug ht that AMH uses the 
sig nal tran sduc tion system that has been iden ti-
fi ed for the ot her fac to rs of the fa mi ly, no tab ly 
TGFβ it se lf, ac ti vin and the bo ne mor pho ge ne tic 
pro tei ns (BMPs). The se fac to rs sig nal throu gh a se-
ri ne–threo ni ne ki na se re cep tor com plex con sis ti-
ng of li ga nd-spe ci fi c type II re cep to rs and mo re 
ge ne ral type I re cep to rs, al so known as ac ti vin 
recep to r-li ke pro tein ki na ses (AL Ks). An ac ti va ted 
re cep tor com plex phos pho ryla tes and ac ti va tes 
cytop las mic Smad pro tei ns that tran slo ca te to the 
nuc leus and di rec tly or in di rec tly aff e ct ge ne 
expres sion (Figu re 1). For AMH one type II re cep tor 
has been iden ti fi ed (AMHRII) and shown to be spe-
ci fi c and ne ces sa ry for AMH sig na li ng (4). The ge ne 
co di ng for AMH re cep tor is lo ca ted on the lo ng 
arm of chro mo so me 12 (5). The AMHRII ge ne is 
spe ci fi  cal ly expres sed in the go na ds and in the 
me sen chymal cel ls ad ja ce nt to the Mülle rian duc-
ts. Be si des the exclu si ve AMHRII, three can di da te 
AMH type I re cep to rs ha ve been iden ti fi ed to be 
in vol ved in A MH-in du ced Mülle rian du ct reg res-
sion. Howe ver, the re la ti ve con tri bu tion of the se 
three type I re cep to rs to AMH sig na li ng in the ova-
ry re mai ns to be de ter mi ned (6).
AMH throug hout the hu man li fe
Pre na tal sta ge
AMH plays fun da men tal ro le in fe tal sex diff e ren-
tia tion. Be fo re the 7th week of ges ta tion, ma le and 
fe ma le fe tu ses ha ve in diff e re nt go na ds, bi po ten-
tial exter nal ge ni ta lia, and two pai rs of uni po ten-
tial in ter nal duc ts (the Mülle rian duc ts and the 
Wol ffi  an duc ts). In the XY fe tus, the expres sion of 
the SRY ge ne trig ge rs tes ti cu lar diff e ren tia tion (7). 
From the 8th ges ta tio nal week, the so ma tic cel ls of 
the de ve lo pi ng tes tes, the Leydig cel ls and Ser to li 
cel ls, pro du ce three hor mo nes that are es sen tial 
for the cor re ct diff e ren tia tion of the in di vi dual in 
the ma le di rec tion. The ste roid hor mo ne tes tos te-
ro ne, pro du ced by the Leydig cel ls, sti mu la tes de-
ve lop me nt of the ma le sex cha rac te ris ti cs, su ch as 
diff e ren tia tion of the Wol ffi  an duc ts in to epi di dymi-
des, va sa de fe ren tia and se mi nal ve sic les (7). In su li-
n-li ke fac tor 3, a mem ber of the re laxin–in su lin fa-
mi ly, is al so pro du ced by the Leydig cel ls, and is an 
es sen tial sig nal for the fi r st pha se of tes tes des ce-
nt. AMH is pro du ced by the Ser to li cel ls of the tes-
tes and is res pon sib le for the reg res sion of the 
Mülle rian duc ts that in the fe ma le fe tus diff e ren-
tia te in to the ovi duc ts, the ute rus and the up per 
por tion of the va gi na (8,9). Ab se nt du ri ng fe ma le 
sex diff e ren tia tion, AMH is fi r st expres sed af ter 36 
wee ks of in trau te ri ne li fe in the gra nu lo sa cel ls of 
ova ries (10).
From bir th to pu ber ty
In pre pu ber tal boys, Leydig cel ls pro du ce low 
amoun ts of tes tos te ro ne. Ser to li cel ls are sti ll im-
ma tu re and sper mio ge ne sis is ar res ted in a pre-
meio tic sta ge, whi le AMH re mai ns sec re ted at hi gh 
le vel ti ll the on set of pu ber ty (9). The re fo re, se rum 
AMH in ma le in fan ts refl ec ts the fun ction of tes tes 
re liab ly and can al so be used in cryptor chi dic ma-
les as the ini tial la bo ra to ry te st to as se ss the pre-
sen ce of the tes tes (9).
In newbo rn gir ls, ova ries con tain pri mor dial fol lic le 
pool con tai ni ng 1-2 mil lion of oo cytes ar res ted in 
the dip lo te ne sta ge of meio tic prop ha se I and sur-
roun ded by fl at te ned pre-gra nu lo sa cel ls (11). The-
se pri mor dial fol lic les stay in their ar res ted sta te for 
yea rs ti ll the on set of pu ber ty. AMH is expres sed in 
FI GU RE 1. AMH re cep tor bin di ng. The pri ma ry re cep tor, type II, 
bin ds its li ga nd and is co-expres sed wi th type I re cep tor whi-
ch ser ve as a sig nal tran sdu cer. Af ter bei ng ac ti va ted, the type 
I re cep tor is phos pho ryla ted by AMH-RII. The ac ti va ted type I 
re cep tor, in tu rn, phos pho ryla tes downstream Sma ds pro tei ns. 
Phos pho ryla ted recep to r-spe ci fi c Sma ds tran slo ca te to the nuc-
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gra nu lo sa cel ls of growi ng fol lic les and con ti nues 
to be pre se nt throug hout the rep ro duc ti ve ages 
(4). In gir ls, AMH cir cu la ti ng va lues are al mo st un-
de tec tab le at bir th wi th a slig ht in crea se wit hin the 
fi r st yea rs of age, prior to pu ber ty.
Pu ber ty and adul thood
In boys, wi th the on set of pu ber ty the sec re tion of 
hypot ha la mic go na dot ro pin re lea si ng hor mo ne 
(GnRH) and bo th go na dot ro pi ns, lu tei ni zi ng hor-
mo ne (LH) and fol lic le-sti mu la ti ng hor mo ne (FSH), 
in crea se. Leydig cel ls un der go fur ther diff e ren tia-
tion. Tes tos te ro ne synthe sis in crea ses, whi ch al so 
in vo kes ma tu ra tion of Ser to li cel ls. Ger mi nal cel ls 
un der go meio sis and sper ma to ge ne sis be gi ns. 
The in hi bi to ry eff e ct of tes tos te ro ne pre vai ls over 
FSH sti mu la tion, re sul ti ng in down-re gu la tion of 
AMH expres sion and the cir cu la ti ng le ve ls ra pid ly 
dec rea se. The sec re tion of AMH reac hes va lues in 
adu lt ma les and is main tai ned al mo st con sta nt un-
til the re st of me n’s li fe (9).
In gir ls, the ri se of ova rian es tra diol synthe sis and 
ac ti va tion of the hypot ha la mus–pi tui ta ry–ova rian 
axis oc cu rs wi th the on set of pu ber ty. Oo cytes at 
the fi r st meio tic prop ha se un der go at re sia or re su-
me meio sis af ter ac ti va tion by an ovu la tio n-in du-
ci ng LH sur ge to fo rm the hap loid ga me te for fer ti-
li za tion (11). AMH is pro du ced by ova ries and sec-
re ted in to the blood stream. It is fi r st expres sed in 
gra nu lo sa cel ls of the rec rui ted pri mor dial fol lic les 
and con ti nues to be expres sed in the growi ng fol-
lic les in the ova ries un til they ha ve reac hed the si-
ze of about 4-6 mm. At that diff e ren tia tion sta te, 
usual ly one fol lic le is se lec ted for do mi nan ce and 
its fur ther growth is con trol led by ac tion of pi tui ta-
ry FSH (12). Pos sib le ac tio ns of AMH in the ova ry 
are pre sen ted in fi  gu re 2.
Physio lo gy and pat hop hysio lo gy of AMH 
in ma les
An ti-Mülle rian hor mo ne is the ear lie st Ser to li ce ll 
hor mo ne sec re ted in ma les and, to get her wi th in-
hi bin B and FSH, is an im por ta nt in di ca tor of Ser to-
li ce ll fun ction (13). The pos tna tal pro li fe ra tion of 
Ser to li cel ls is es sen tial for sper ma to ge ne sis, du ri-
FI GU RE 2. Model of AMH ac tio ns in the ova ry. AMH is expres-
sed in pri ma ry, pre-an tral and sma ll an tral fol lic les. Ini tial rec-
ruit me nt of pri mor dial fol lic les ta kes pla ce as a con ti nuous pro-
ce ss, whe reas cyclic rec ruit me nt is dri ven by a ri se in FSH se rum 
le ve ls at the end of a pre vious men strual cycle. AMH in hi bi ts (–) 
the ini tial rec ruit me nt of pri ma ry fol lic les from the res ti ng pri-
mor dial fol lic le pool and the sti mu la to ry eff e ct of FSH on the 
growth of prean tral and sma ll an tral fol lic les (+) (4).
ng whi ch the tran sie nt GnRH sur ge oc cu rs. In the 
fi r st wee ks of newbo rn ma le, the in fan ti le GnRH 
sur ge in du ce a sig ni fi  ca nt in crea se of go na dot ro-
pi ns (LH and FSH), fol lowed by the in crea sed tes-
tos te ro ne pro duc tion in Leydig cel ls, as we ll as 
AMH and in hi bin B in Ser to li cel ls of tes tes (9). The-
se unexpec ted hi gh le ve ls of an dro ge ns and AMH 
in the fi r st mon ths af ter bir th are explai ned by the 
physio lo gi cal an dro gen in sen si ti vi ty of Ser to li cel ls 
in the se pe rio ds due to the la ck of an dro gen re-
cep tor expres sion in Ser to li ce ll nuc lei (9).
This sta ge, so cal led „mi ni-pu ber ty“, has been pro-
po sed as the fi r st op por tu ni ty to de te ct pa tien ts 
wi th hypo go na dot ro pic hypo go na di sm (HH), sin-
ce it can not be ob ser ved in boys wi th con ge ni tal 
HH (14). Thus, dec rea sed AMH se rum le vel, com pa-
red to that in in fan ts of the cor res pon di ng age, is 
an ear ly bioc he mi cal mar ker of con ge ni tal cen tral 
hypo go na di sm. AMH leve ls re main hi gh du ri ng 
the who le pre pu ber tal pha se and are downre gu la-
ted in pu ber ty by in crea sed tes tos te ro ne le ve ls. 
Se rum AMH le ve ls in ma les, ac cor di ng to age, are 
shown in tab le 1 (15).
Posible actions of AMH in the ovary:
– Inhibition of follicular activation and growth
– Inhibition of FSH stimulated growth
– Inhibition of granulosa cell growth
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The as ses sme nt of AMH (a nd in hi bin B) can be use-
ful in the diff e ren tial diag no sis of con sti tu tio nal 
de lay of growth and pu ber ty when AMH se rum le-
ve ls re main at hi gh pre pu ber tal va lues, whi le low 
AMH (a nd in hi bin B) le ve ls at the age of physio lo-
gi cal pu ber ty are in di ca ti ve for the con ge ni tal 
hypo go na di sm (9).
Kli ne fel ter syndro me is the mo st com mon con ge-
ni tal cau se of hyper go na dot ro pic hypo go na di sm. 
The main cli ni cal fea tu res in clu de gyne co mas tia, 
sma ll tes tes, ab se nt sper ma to ge ne sis, nor mal or 
re du ced Leydig ce ll fun ction and ele va ted FSH le-
ve ls. This di sor der is cau sed by a su per nu me ra ry X 
chro mo so me (ka ryo type 47,XXY or mo sai ci sm 
46,XY/47,XXY). At the ti me when nor mal pu ber ty is 
expec ted, la bo ra to ry fi n din gs are cha rac te ri zed by 
the sig ni fi  can tly in crea sed FSH and LH le ve ls, low 
tes tos te ro ne, dec rea sed AMH and un de tec tab le 
in hi bin B se rum le ve ls (17).
Asses sme nt of AMH (a nd in hi bin B) rep re sen ts a 
pro mis so ry ap proa ch in ot her cau ses of ma le 
hypo go na di sm. For exam ple, acqui red hyper go-
na dot ro pic hypo go na di sm can be cau sed by au-
toim mu ne di sea ses, che mot he ra py and/or ra dia-
tion the ra py for ma lig na nt neop la sm that aff e ct 
tes ti cu lar tis sue and fun ction (18).
The mea su re me nt of cir cu la ti ng AMH can al so be 
use ful in in fan ts wi th bi la te ral no n-pal pab le go nad 
(cryptor chi di sm) as evi den ce that the tes tes can be 
pre se nt but not des cen ded. If ne ces sa ry, the hCG 
sti mu la tion te st is re com men ded to as se ss the pre-
sen ce of fun ctio ni ng tes ti cu lar tis sue and the de-
tec tion of de fec ts in tes tos te ro ne bio synthe sis by 
Leydig cel ls and its ac tion (18).
AMH see ms to be a good can di da te mar ker for in-
com ple te or re du ced sper ma to ge ne sis sin ce it is 
spe ci fi  cal ly sec re ted by Ser to li cel ls in bo th se rum 
and se mi nal fl uid in de tec tab le con cen tra tio ns. Se-
rum AMH see ms to be sig ni fi  can tly lower in no n-
ob struc ti ve azoos per mic men than in tho se wi th 
ob struc ti ve azoos per mia and nor mal fer ti le man. 
Howe ver, the wi de over lap pi ng of va lues be tween 
sub jec ts pre ven ts this hor mo ne from bei ng of cli-
ni cal uti li ty (19).
If Ser to li cel ls are unab le to pro du ce AMH, be cau se 
of mu ta tio ns in the AMH ge ne, or if tar get or ga ns 
are un res pon si ve to its ac tion throu gh mu ta tio ns 
of the AMHRII ge ne, Mülle rian du ct de ri va ti ves wi ll 
be re tai ned in ge ne tic ma le, ot he rwi se nor mal ly 
mas cu li ni zed. This con di tion is known as the per-
sis te nt Mülle rian du ct syndro me (PMDS). In pa tien-
ts wi th mu ta tio ns of the AMH ge ne, le ve ls of cir cu-
la ti ng AMH are extre me ly low, even be fo re pu ber-
ty, when AMH le ve ls are nor mal ly hi gh. AMH con-
cen tra tio ns are hig her in pa tien ts wi th re cep tor 
type II (AMHRII) ge ne mu ta tio ns (20).
The ro le of AMH in ova rian re ser ve 
eva lua tion
AMH is pro du ced by gra nu lo sa cel ls of growi ng 
fol lic les, from pre-an tral to an tral sta ge, un til they 
rea ch the si ze of 4-6 mm (21). AMH expres sion di-
sap pea rs in fol lic le of in crea si ng si ze and is al mo st 
lo st in fol lic les lar ger than 8 mm (22). The main 
physio lo gi cal ro le of AMH in the ova ry see ms to be 
tar ge ted to the in hi bi tion of pri mor dial fol lic le rec-
ruit me nt, thus pre ven ti ng too ear ly dep le tion of 
the fol li cu lar re ser ve. Bo th in vi vo and in vit ro expe-
ri men ts ha ve in di ca ted that the tran si tion from pri-
mor dial in to growi ng fol lic les be co mes en han ced 
in ab sen ce of AMH (23). Fur ther mo re, the in hi bi-
tion of sen si ti vi ty to FSH by AMH is a de ci si ve step 
Age group N
Serum AMH (pmol/L)
Mean ± SEM* 95% Cl**
<15 days 6 229 ± 59 76–381
15 days–1 year 22 465 ± 93 251–679
1–4 yea rs 17 499 ± 66 360–638
4–7 yea rs 16 438 ± 61 309–566
7–9 yea rs 14 336 ± 47 234–438
>9 yea rs ***I 22 249 ± 26 194–304
>9 yea rs *** II 25 159 ± 25 107–211
>9 yea rs *** III 8 79 ± 28 12–145
>9 yea rs *** IV–V 8 48 ± 14 14–81
Adul ts 21 30 ± 4 22–38
* SEM – stan da rd er ror of the mean = SD/(square root of 
sam ple si ze)
** 95% con fi  den ce in ter val
*** Pu ber tal sta ges ac cor di ng to Mar sha ll and Tan ner (16).
TAB LE 1. Se rum AMH in nor mal ma les.
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in fol li cu lar se lec tion and it may oc cur due to the 
va riab le expres sion of AMH re cep to rs amo ng the 
rec rui ted sma ll pre-an tral fol lic les. In su ch cir cum-
stan ces, out of the ini tial ly rec rui ted fol lic le uni ts, 
on ly tho se wi th lower AMH expres sion be co me 
sen si ti ve to FSH, of whi ch usual ly one is per mit ted 
for do mi nan ce. The re fo re, AMH ac ts as an au toc ri-
ne fac tor that re gu la tes do mi na nt fol lic le se lec tion. 
Cur re nt theo ries al so sug ge st a ro le for AMH as a 
co-re gu la tor of ste roi do ge ne sis in gra nu lo sa cel ls, 
as AMH le ve ls ap pear to be re la ted to es tra diol le-
ve ls in fol li cu lar fl uid from sma ll an tral fol lic les (24). 
This is con fi r med in a stu dy whi ch showed that po-
lymor phis ms in the ge ne for AMH or AMHRII seem 
to be re la ted to fol li cu lar pha se es tra diol le ve ls, 
sug ges ti ng a ro le for AMH in the FSH-in du ced ste-
roi do ge ne sis in the hu man ova ry (25).
The expres sion of AMH in pre-an tral and sma ll an-
tral fol lic les main ly con tri bu tes to its se rum le ve ls 
du ri ng the rep ro duc ti ve li fe. An ac ti ve co ho rt of 
growi ng fol lic les rep re sen ts the an tral fol lic le cou-
nt (AFC), whi ch al so ser ves as a mar ker of ova rian 
re ser ve and stron gly cor re la tes wi th se rum AMH 
le ve ls (26). Des pi te this cor re la tion, AFC poor ly ref-
le ct the pre-an tral fol lic le pool and, mo reo ver, 
requi res sta te-o f-the-a rt ultra sou nd mac hi ne and 
expe rien ced ul tra so nog rap hi st (27). The re fo re, 
AMH may pro vi de a more ac cu ra te as ses sme nt of 
the oo cyte/follicle pool. Con tra ry to the ot her ova-
rian re ser ve mar ke rs, AMH can be mea su red at any 
ti me du ri ng the men strual cycle due to in sig ni fi  ca-
nt in tra-cycle va ria bi li ty, whi ch is a great ad van ta-
ge in cli ni cal prac ti ce (28,29). In the lon gi tu di nal 
stu dy of se rum AMH le ve ls in whi te, bla ck and His-
pa nic wo men, aut ho rs fou nd cer tain, but in sig ni fi -
ca nt diff e ren ces in mea su red va lues in re la tion to 
ra ce/ethnicity (30). AMH le ve ls are not chan ged 
du ri ng preg nan cy, du ri ng whi ch en do ge nous go-
na dot ro pin re lea se is sub stan tial ly di mi nis hed (31). 
In ad di tion, AMH le ve ls re main stab le du ri ng oral 
con tra cep ti ve ad mi nis tra tion (32). The se fi n din gs 
are con sis te nt wi th the con ce pt that AMH le ve ls 
refl e ct the con ti nuous FSH-in de pen de nt no n-
cyclic growth of sma ll fol lic les in the ova ry. Hen ce, 
AMH is a unique en doc ri ne pa ra me ter for the in-
ves ti ga tion of the ova rian re ser ve (33).
Sti ll, the Free man’s cro ss-sec tio nal stu dy in heal-
thy, re gu lar ly men strua ti ng wo men has shown a 
sig ni fi  ca nt in ver se as so cia tion of AMH se rum le ve ls 
and bo dy-ma ss in dex (BMI) (34). In obe se wo men, 
mean AMH le ve ls we re 65% lower than AMH le ve ls 
of no n-o be se wo men. In ad di tion, a mul ti va riab le 
reg res sion ana lysis of in de pen de nt as so cia tion of 
va riab les BMI, age, me no pau sal status and ra ce wi-
th AMH con fi r med that BMI re mai ned sig ni fi  can tly 
as so cia ted wi th AMH le ve ls. The aut ho rs sug ges-
ted two pos sib le expla na tio ns for the fi n di ng: eit-
her obe si ty may be as so cia ted wi th dec rea sed ova-
rian re ser ve, or obe si ty is as so cia ted wi th fol li cu lar 
dysfun ction. The weak ne ss of the stu dy is that 
blood sam ples we re se lec ted in a co ho rt of wo-
men in la te rep ro duc ti ve ages (35-47 yea rs) and 
the dis tri bu tion of stu died va riab les may not be 
rep re sen ta ti ve for the en ti re ran ge of rep ro duc ti ve 
li fe.
AMH as in di ca tor of ova rian agi ng 
throug hout rep ro duc ti ve li fe
Tren ds in mo de rn so cie ties ha ve been ac com plis-
hed al so wi th ma ter ni ty pos tpo ne me nt and the in-
crea si ng de ma nd for as sis ted rep ro duc tion tec-
hniques (ART) (35). Be cau se of a con si de rab le pro-
por tion of sub fer ti le wo men, the as ses sme nt of 
ova rian re ser ve be co mes of cru cial in te re st in wo-
men pre sen ti ng to fer ti li ty cli ni cs.
As a wo man ages the re is a gra dual dec rea se in 
bo th quan ti ty and qua li ty of the oo cytes re si di ng 
wit hin fol lic les, ac com pa nied by a con co mi ta nt 
dec rea se in AMH se rum con cen tra tion. It has been 
de mon stra ted that AMH le ve ls cor re la te stron gly 
wi th AFC and are mo re re liab le in pre dic ti ng oo-
cyte sup ply than wo man’s age and ot her con ven-
tio nal se rum mar ke rs (FSH, es tra diol) (36). In ves ti-
ga tion of age-de pen de nt re fe ren ce va lues for 
AMH shou ld pro vi de a bet ter in sig ht in cu to ff  le ve-
ls throug hout the rep ro duc ti ve li fe of wo men. Re-
cen tly, in two exten si ve stu dies, age-spe ci fi c dis tri-
bu tio ns of AMH in fe ma le po pu la tion we re exa mi-
ned (37,38). In wo men, be tween 25 and 35 yea rs of 
age, the ave ra ge dec rea se in the me dian se rum 
AMH va lue is 1.4 pmol/L (0.2 ng/mL) per year, whi-
le af ter age of 35, the ave ra ge year ly dec rea se is 0.7 
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pmol/L (0.1 ng/mL). The ra te of dec li ne in mean 
AMH va lues is 1.4 pmol/L (0.2 ng/mL) per year 
throu gh age 40 and di mi nis hes to 0.7 pmol/L (0.1 
ng/mL) per year the reaf ter (37).
Du ri ng the yea rs be fo re the fi  nal men strual pe riod, 
oo cytes un der go an ac ce le ra ted ra te of lo ss un til 
their pool is mos tly dep le ted. A hypot he sis stan ds 
that this pro ce ss is ini tia ted when the to tal of num-
ber of oo cytes reac hes ap proxi ma te ly 25,000 and 
that wo man, un der physio lo gi cal con di tion, reac-
hes this thres ho ld at about 37-38 yea rs of age (42). 
At me no pau se, the num ber of oo cytes has dec rea-
sed to so me hun dre ds (43).
Per ha ps, one of the out stan di ng chal len ges nowa-
days is the la ck of re fe ren ce va lues of AMH in heal-
thy fe ma le po pu la tion of rep ro duc ti ve age (39). 
This is mos tly due to the fa ct that the da ta ha ve 
been ob tai ned from in fer ti li ty cli ni cs and/or cen te-
rs for rep ro duc ti ve me di ci ne whe re the ma jo ri ty of 
wo men un der go la bo ra to ry tes ts for ART pro ce du-
res. She bl and cowor ke rs pre sen ted ba sal se rum 
AMH le ve ls in wo men who at ten ded an ART prog-
ram be cau se of ma le fac tor (38). This pre su mab ly 
heal thy co ho rt con sis ted of ovu la to ry wo men in 
rep ro duc ti ve ages, wit hout is sues re la ted to ab-
nor mal ova rian fun ction (e.g., tu bal fac tor, en do-
met rio sis, po lycystic ova ries). Eva lua ted me dian 
con cen tra tio ns and con fi  den ce in ter va ls for ba sal 
se rum AMH ac cor di ng to age are shown in tab le 2 
(supplementary data available online).
Anot her two stu dies from Scot la nd ha ve been 
pub lis hed mo st re cen tly, pro po si ng a po pu la tion 
mo del for se rum AMH le ve ls (40,41). Ac cor di ng to 
the ob ser va tio ns, AMH va lues exhi bit the grea te st 
he te ro ge nei ty and spread in ab so lu te values in 
youn ger wo men, sug ges ti ng that they are pre sen-
ti ng wi th a wi der ran ge of de ve lop me nt of A MH-
expres si ng fol li cu lar co hor ts as com pa red wi th ol-
der wo men. Al so, it may be that they exhi bit diff e-
ren tial AMH expres sion for their age mat ched fol li-
cu lar pool (40). The mo del of the as so cia tion of 
AMH con cen tra tio ns wi th age con fi r med a non li-
near dec rea si ng ra te of AMH wi th age; the no mog-
ram for wo men be tween 25 and 45 yea rs is be st 
des cri bed by a quad ra tic equa tion: log AMH = a + 
b x Age + c x Age2. In this equa tion, log AMH is na-
tu ral lo ga rit hm of AMH, a = 1.932 (95% con fi  den ce 
in ter val – CI, 1.891 to 1.973), b = -0.138 (-0.149 to 
-0.127) and c = -0.003 (-0.005 to -0.002) (40). In the 
sub seque nt stu dy, Kel sey and cowor ke rs ge ne ra-
ted the fi r st va li da ted mo del of se rum AMH in 
heal thy fe ma les from con cep tion to me no pau se; 
the re sul ts ha ve been de ri ved from 3,260 da ta 
extrac ted from pre vious ly pub lis hed con trol and/
or pros pec ti ve stu dies in heal thy fe ma le sub jec ts 
(41). They ha ve even in clu ded the da ta from co rd 
blood of pre te rm in fan ts up to tho se in fe ma les of 
54.3 yea rs of age. As to the mo del of se rum AMH 
throu gh the fe ma les’ li fe, con cen tra tio ns fa ll shor-
tly af ter bir th, in crea se slig htly at about two yea rs 
of age and then ri se sig ni fi  can tly wi th the on set of 
pu ber ty. In te res tin gly, the aut ho rs sug ge st that 
AMH se rum le ve ls rea ch a peak at about 24.5 yea rs 
of age and then gra dual ly dec rea se, in a non li near 
man ner, throu gh the pe riod of wo men’s rep ro duc-
ti ve li fe (41).
For yea rs, se rum le ve ls of FSH and es tra diol ha ve 
been the de ci si ve bioc he mi cal mar ke rs in as ses-
sme nt of di mi nis hi ng ova rian fun ction, but FSH 
ten ds to ri se over ba sal va lues in fol li cu lar pha se of 
the men strual cycle on ly when ova rian re ser ve is 
sig ni fi  can tly exhaus ted and ova rian fun ction al rea-
dy com pro mi sed (44). Mo re fa vo rab le re sul ts ha ve 
been ob tai ned usi ng AMH as a mar ker, for it refl ec-
ts the fol li cu lar co ho rt as a who le, in clu di ng sti ll 
inac ti ve fol lic les and tho se bei ng tran si ted from 
pri mor dial to the ear ly an tral sta ge. It has been as-
su med that a thres ho ld of 2.8 pmol/L (0.39 ng/mL) 
for AMH has the op ti mal com bi ned sen si ti vi ty and 
spe ci fi  ci ty for pre dic tion of the on set of me no pau-
se in six yea rs, wi th a po si ti ve pre dic ti ve va lue of 
0.90 (95% CI, 0.81-0.96) and ne ga ti ve pre dic ti ve va-
lue of 0.76 (95% CI, 0.65-0.86), res pec ti ve ly (45).
AMH as a mar ker of pre ma tu re ova rian 
se nes cen ce
It is con si de red that fol li cu lar exhaus tion be co mes 
ob vious in the four th de ca de of wo man’s li fe when 
chan ges in the go na dal en vi ron me nt oc cur, al thou-
gh the ma jo ri ty of wo men of that age con ti nue wi th 
ap pa ren tly nor mal men strual cycles (46). The mo st 
re ce nt stu dy in a po pu la tion of pre su mab ly heal thy 
wo men has shown that in ap proxi ma te ly 5% of wo-
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men of all ages, AMH se rum le ve ls are ≤ 7 pmol/L (1 
ng/mL) (38). This fi n di ng has un doub ted ly poin ted 
to the fa ct that all age sub grou ps com pri se wo men 
wi th a re du ced ova rian re ser ve and that even you-
ng wo men are at ri sk of dec rea sed rep ro duc ti ve po-
ten tial.
Pre ma tu re ova rian fai lu re is cli ni cal ly de fi  ned as 
the com ple te ab sen ce of men strual cycles be fo re 
the age of 40, wi th FSH le ve ls excee di ng 40 IU/L and 
AMH le ve ls be low the me no pau sal thres ho ld or 
even un de tec tab le in mo st of the ca ses (46). Pre ma-
tu re ova rian agei ng rep re sen ts a mil der deg ree of 
go na dal dysfun ction whi ch is cha rac te ri zed wi th 
ba se li ne FSH < 12 IU/L and/or ab nor mal ly low age-
spe ci fi c AMH (46,47). It has been ar gued that AMH 
off e rs bet ter cli ni cal spe ci fi  ci ty for the rea son that 
FSH is mos tly refl ec ti ve of la te-sta ge, go na dot ro pi n-
sen si ti ve, fol lic les pre ce di ng ovu la tion (48). In anot-
her wor ds, AMH and FSH diff e ren tly refl e ct ova rian 
re ser ve at diff e re nt sta ges of li fe.
The pres ti gious re sul ts in the re ce nt Gleic he r’s stu-
dies pos tu la te that the in crea si ng trip le CGG (Cyto-
si ne-Gua ni ne-Gua ni ne) re pea ts on the FMR1 (fra gi-
le X) ge ne cor re la te wi th spe ci fi c ova rian re ser ve 
pa ra me te rs, and are as so cia ted wi th pre ma tu re 
ova rian se nes cen ce and in fer ti li ty in you ng wo-
men (49). The sig ni fi  ca nt as so cia tio ns be tween 
FMR1 ge no types and AMH le ve ls cou ld al low pre-
dic tio ns about the fun ctio nal ova rian re ser ve al-
rea dy in you ng ages (50).
AMH as a pre dic tor of suc ce ss in as sis ted 
rep ro duc tion tec hniques (ART)
The rep ro du ci bi li ty of AMH be tween con se cu ti ve 
cycles in the sa me wo man, in dis tin ction from FSH, 
es tra diol and in hi bin B, per mi ts cli ni cia ns to ha ve a 
re liab le se rum mar ker in pre dic tion of ova rian res-
pon se in as sis ted rep ro duc tion cycles. Mu ch da ta 
show a stro ng and po si ti ve cor re la tion be tween 
ba sal AMH se rum le ve ls and the num ber of ret rie-
ved oo cytes in wo men un der goi ng ova rian sti mu-
la tion (35). Mo reo ver, ba sal se rum AMH va lue and 
an tral fol lic le cou nt (AFC) ha ve shown a si mi lar 
power in pre dic tion of the num ber of ret rie ved oo-
cytes (35,51). In me ta-a na lysis of about 30 stu dies, 
re cei ver ope ra ti ng cha rac te ris tic (RO C) cur ves for 
the pre dic tion of ova rian res pon se in di ca ted no 
sig ni fi  ca nt diff e ren ce be tween the per for man ces 
of AMH and AFC (52). The num ber of de ve lo ped 
fol lic les and the num ber of ret rie ved oo cytes are 
two of the mo st im por ta nt cri te ria for de fi  ni ng 
poor res pon se in wo men un der goi ng ova rian sti-
mu la tion for in-vit ro fer ti li za tion (IVF) (35).
For in stan ce, Ba rad and co-wor ke rs fou nd that 
AMH cu t-o ff  va lue of 3.5 pmol/L (0.5 ng/mL) cou ld 
pre di ct the ret rie val of le ss than four oo cytes wi th 
a spe ci fi  ci ty of 84% and sen si ti vi ty of 87% (48). At 
this dis cri mi na to ry AMH va lue, the po si ti ve and 
ne ga ti ve pre dic ti ve va lues we re 79.4% and 90%, 
res pec ti ve ly. In con tra st, a va lue of FSH > 12 IU/L 
had sen si ti vi ty of 64.5% and spe ci fi  ci ty of 82.2%, 
wi th po si ti ve and ne ga ti ve pre dic ti ve va lues of 
71.4% and 77%, res pec ti ve ly (51).
Ulti ma te ly im por ta nt is, howe ver, whet her as ses-
sme nt of AMH can pre di ct chan ce for preg nan cy 
and li ve bir ths in IVF cycles. In the next stu dy of 
the men tio ned aut ho rs, maxi mal ROC in fl ec tio ns, 
whi ch diff e ren tia te be tween bet ter and poo rer li-
ve bir th chan ces in wo men wi th di mi nis hed ova-
rian re ser ve (DOR), we re at AMH cu t-o ff  < 7.5 pmol/L 
(1.05 ng/mL). Sti ll, it was de mon stra ted that cli ni cal 
preg nan cies cou ld be es tab lis hed at all AMH le vel, 
even in the ab sen ce of de tec tab le AMH (53).
AMH as a mar ker of ova rian 
pat hop hysio lo gy
Po lycystic ova rian syndro me (PCOS)
PCOS is the mo st freque nt en doc ri ne di sor der of 
ova rian fun ction, wi th a pre va len ce of 6-7% amo-
ng wo men of rep ro duc ti ve age (54). It has been 
known for yea rs that it rep re sen ts mo re com plex 
en ti ty than so le ly an ova rian dysfun ction. In crea-
sed an dro gen synthe sis, dis rup ted fol li cu lo ge ne sis 
and in su lin re sis tan ce are the ma ni fes ta tion of en-
doc ri ne/reproductive and me ta bo lic dis tur ban ces 
of the im pai red mo le cu lar mec ha nis ms known to 
un der lie PCOS. Ac cor di ng to the Rot ter dam con-
sen sus, the diag no sis shou ld meet at lea st two, of 
the three fol lowi ng cri te ria: chro nic ano vu la tion or 
oli go me nor r hea, cli ni cal or bioc he mi cal hype ran-
dro ge ni sm and po lycystic ova rian mor pho lo gy 
(55). An ul tra sou nd exa mi na tion re vea ls in crea sed 
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ova rian vo lu me and/or the pre sen ce of ≥ 12 fol lic-
les in ea ch ova ry. It has been hypot he si zed that 
the in crea sed in tra fol li cu lar AMH le ve ls, fou nd in 
PCOS, lower the fol lic le sen si ti vi ty to cir cu la ti ng 
FSH, thus pre ven ti ng fol lic le se lec tion and re sul ti-
ng in fol lic le ar re st at the sma ll an tral pha se (2-5 
mm) (56). The ba lan ce be tween FSH and AMH mig-
ht be cru cial for aro ma ta se ac ti vi ty at the ti me and 
af ter the se lec tion of the do mi na nt fol lic le. Dec rea-
sed FSH ac tion in hi bi ts aro ma ta se ac ti vi ty in syner-
gy wi th AMH, hin de ri ng the con ver sion of an dro-
ge ns to es tro ge ns, thus con tri bu ti ng to ova rian an-
dro gen exce ss and re duc tion of fol li cu lar pro duc-
tion of es tra diol. The re sul ti ng low le ve ls of es tra diol 
may al so con tri bu te to the fai lu re of fol lic le se lec-
tion. In crea sed AMH le ve ls may al so act di rec tly on 
the ca cel ls to sti mu la te an dro gen synthe sis (54).
Cir cu la ti ng AMH le ve ls in wo men wi th PCOS are 
two to three ti mes hig her than in heal thy con tro ls, 
cor res pon di ng to the in crea se in the num ber of 
sma ll fol lic les in ova ries (54).
As a diag nos tic mar ker of PCOS, AMH has been 
fou nd to off er a re la ti ve ly hi gh spe ci fi  ci ty and sen-
si ti vi ty (92% and 67%, res pec ti ve ly) (56). Mo reo ver, 
eva lua tion of ba sal AMH le ve ls in wo men wi th 
PCOS plays an im por ta nt ro le in pre dic ti ng the ri sk 
for ova rian hype r-res pon se and in for mi ng a cli ni-
cian to di re ct the ap pli ca tion of mi ld sti mu la tion 
pro to co ls in or der to avoid ova rian hyper sti mu la-
tion syndro me (OHSS) (35,36).
Po lymor phis ms of AMH and AMHRII ge nes as
cau ses of in fer ti li ty
Two ge nes are res pon sib le for the AMH sig nal tran-
sduc tion pat hway (AMH ge ne and its re cep tor AM-
HRII ge ne), con fi r mi ng their as so cia tion wi th fol li-
cu lar pha se es tra diol le vel (25). AMH is pro du ced 
by gra nu lo sa cel ls in ear ly de ve lo pi ng fol lic les, whi-
ch in di ca tes its ro le du ri ng the ini tia tion of pri mor-
dial fol lic le growth and in re gu la tion of FSH sen si ti-
vi ty. As shown in a re ce nt stu dy, ge ne tic va rian ts of 
AMH and AMHRII ge nes seem to be as so cia ted 
with idio pat hic in fer ti li ty in nor mo-es tro ge nic and 
nor mo-o vu la to ry wo men (57). The re sul ts sug ge st 
that AMH po lymor phis ms cou ld mo di fy hor mo ne 
bio lo gi cal ac ti vi ties, playi ng a ro le in con trol li ng 
fol lic le rec ruit me nt and growth. Al thou gh in the 
sma ll sam ple si ze, the ge no typi ng has shown that 
al le le frequen cies of –482 A>G, IVS 5–6 C>T, IVS 
10+77 A>G, 146T>G po lymor phis ms are sta tis ti cal-
ly sig ni fi  can tly in crea sed in the in fer ti le wo men 
com pa red wi th the con tro ls (57). Al thou gh it see-
ms plau sib le that po lymor phis ms of AMH and AM-
HRII mig ht re du ce the hor mo ne bio lo gic ac ti vi ty, 
ma ki ng fol lic les mo re sen si ti ve to FSH, fur ther in-
ves ti ga tio ns are expec ted to cla ri fy their as so cia-
tion wi th unexplai ned in fer ti li ty in wo men.
Mülle rian ap la sia or Maye r-Ro ki tan sky-Küste r-
Hau ser syndro me
Mülle rian age ne sis, al so na med the Maye r-Ro ki-
tan sky-Küste r-Hau ser syndro me (MRKHS), is the 
se co nd mo st com mon cau se of pri ma ry ame nor r-
hea (58). Al thou gh the etio lo gy of the syndro me 
re mai ns un clear, evi den ces sug ge st that MRKHS is 
tran smit ted in an au to so mal do mi na nt man ner 
cau si ng de fec ts in pre na tal de ve lop me nt in the fe-
ma le ge ni tal tra ct. It is cha rac te ri zed by the con ge-
ni tal ab sen ce of the Mülle rian struc tu res in clu di ng 
the Fal lo pian tu bes, the ute rus, and the in ter nal 
por tion of the va gi na in an ot he rwi se chro mo so-
mal ly nor mal 46,XX sub je ct. Fe ma les wi th MRKHS 
ha ve fun ctio ni ng ova ries and nor mal exter nal ge-
ni ta lia. Sti ll, mo le cu lar ana lyses of AMH and AMHRII 
ge nes ha ve not de tec ted any de le te rious mu ta tio-
ns res pon sib le for the syndro me (59). This fi n di ng 
refl ec ts nor mal ly re gu la ted AMH ge ne pro mo te rs, 
tran scrip tion and AMH pro tein pro duc tion in adu lt 
MRKH pa tien ts. As blood AMH le ve ls dec rea se over 
ti me and are as so cia ted wi th the num ber of re mai-
ni ng an tral fol lic les, AMH the re fo re rep re sen ts a 
spe ci fi c mar ker for ova rian age and cou ld be hel-
pful for pre dic ti ng suc ces sful IVF or sur ro ga cy 
preg nan cies in su ch ca ses (58).
AMH as a mar ker of gra nu lo sa ce ll tu mo rs
The sex co rd stro mal neop las ms are de ri ved from 
me sen chymal stem cel ls in the ova rian cor tex; they 
in clu de gra nu lo sa–the ca ce ll tu mo rs and gra nu lo-
sa ce ll tu mo rs (GCTs), whi ch con sti tu te 1-3% of all 
ova rian tu mo rs (60,61). Two dis tin ct types of GCTs 
ha ve been des cri bed on the ba sis of cli ni cal pre-
sen ta tion and his to lo gi cal cha rac te ris ti cs: the ju ve-
ni le and the adu lt fo rm (60). GCTs are hor mo ne-
sec re ti ng neop las ms; they may pro du ce es tra diol 
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and pro ges te ro ne and they sec re te pep ti de hor-
mo nes, su ch as in hi bin and AMH (61). The re fo re, 
se rum AMH ser ves as bioc he mi cal mar ker in diag-
no sis and mo ni to ri ng of the di sea se. Howe ver, se-
rum AMH is ele va ted on ly in sex co rd stro mal tu-
mo rs, whi le in hi bin may be ele va ted in diff e re nt 
types of can cer (60). Glo bal ly, AMH se rum le ve ls 
seem to be ele va ted in 76-93% of GCT pa tien ts 
(61). Al thou gh AMH is con si de red a power ful in hi-
bi tor in gra nu lo sa ce ll pro li fe ra tion, stu dies ha ve 
shown that the in hi bi to ry sig nal is fun ctio nal on ly 
in the ini tial sta ge of tu mor de ve lop me nt, but not 
when the tu mor be co mes prog res si ve and rea ch a 
lar ge di men sion (60). One of the pos sib le theo ries 
is that, in prog res si ve tu mo rs, the abi li ty of bin di ng 
of AMHRII re cep tor by its li ga nd is lo st and that the 
in hi bi to ry sig nal of AMH be co mes ineffi   cie nt (61).
Un for tu na te ly, the agen ts used to treat the ma lig-
nan cies are ab le to des troy a grea ter or les ser num-
ber of ova rian pri mor dial fol lic les in can cer sur vi-
vo rs (62). Ra diot he ra py and che mot he ra py, es pe-
cial ly al kyla ti ng agen ts, cyclop hos pha mi de, bi sul-
phan, mel pha lan, cyto si ne, pro car ba zi ne and ci s-
pla tin are extre me ly har mful to the ova rian re ser ve 
and fun ction (63). In su ch ca ses, the re is a de fi  ni te 
and unquan ti fi ab le be ne fi t of mo ni to ri ng se rum 
AMH le ve ls, be cau se gir ls and you ng wo men are 
at in crea sed ri sk of pre ma tu re ova rian fai lu re as 
we ll as of re du ced rep ro duc ti ve abi li ty. Ba th and 
cowor ke rs ha ve shown that, amo ng pa tien ts wi th 
re gu lar men strual cycles, can cer sur vi vi ng wo men 
ha ve sig ni fi  can tly lower ba sal AMH va lues than 
con tro ls (13.0 ± 3.0 vs. 21.0 ± 3.4 pmol/L; P < 0.05) 
and hig her ear ly fol li cu lar pha se FSH le ve ls (7.5 ± 
1.4 vs. 4.2 ± 0.3 IU/L; P = 0.02) (63). In anot her stu dy, 
Par tri ge and cowor ke rs in ves ti ga ted pa ra me te rs of 
ova rian re ser ve in wo men trea ted wi th ta moxi fen 
and ra diot he ra py for ear ly sta ge brea st can cer (64). 
In uni va ria te lo gis tic ana lyses, AFC, FSH, AMH and 
in hi bin B le ve ls we re all sig ni fi  can tly diff e re nt be-
tween sur vi vo rs and con tro ls, thou gh in a mul tip le 
lo gis tic reg res sion ana lysis, AMH le ve ls dis tin guis-
hed sur vi vo rs from con tro ls wi th the grea te st sta-
tis ti cal diff e ren ce (od ds ra tio 7.63) (64). Al thou gh 
the bo th stu died grou ps, pa tien ts and con tro ls, 
we re adequa te ly mat ched, the li mi ta tion of the 
stu dy is that the pa ra me te rs of ova rian re ser ve had 
not been mea su red be fo re che mot he ra py star ted.
De ve lop me nt of im mu noas says for AMH 
mea su re me nt
The fi r st re por ted AMH im mu noas say used a pair 
of mo noc lo nal an ti bo dies rai sed again st hu man 
re com bi na nt AMH, bo th di rec ted to epi to pes in 
the pro re gion (65). Howe ver, the use of this as say 
showed re sul ts wi th va ria bi li ty in AMH con cen tra-
tio ns due to sto ra ge and free ze-thaw in sta bi li ty. 
The se co nd type of as say used a pair of mo noc lo-
nal an ti bo dies, one di rec ted to the pro re gion and 
the ot her to the ma tu re re gion of the AMH mo le-
cu le (61). A thi rd as say, de ve lo ped mo re re cen tly, 
uses a mo noc lo nal an ti bo dy pair di rec ted to epi to-
pes in the pro re gion (66). The new AMH Gen II as-
say uses a pair of mo noc lo nal an ti bo dies di rec ted 
to epi to pes in the ma tu re re gion of AMH (67). The 
ad van ta ge of this as say is that mea su red va lues are 
not aff ec ted by pro teo lysis of AMH in the sam ple 
as the ma tu re re gion is mo re stab le again st pro-
teo lysis com pa red to the pro re gion, in pa rt due to 
its mul tip le cysti ne re si dues (67). In ad di tion, the 
Gen II as say mea su res AMH in hu man, mon key, bo-
vi ne, ot her mam ma lian spe cies wi th im pro ved 
per for man ce. The lowe st amou nt of AMH in a sam-
ple that can be de tec ted wi th 95% pro ba bi li ty is 
0.57 pmol/L (0.08 ng/mL). The mo noc lo nal an ti bo-
dies are de ve lo ped again st the epi to pes of the ma-
tu re re gion of AMH whi ch pre ven ts any of cro ss 
reac tio ns wi th in hi bin A, LH and FSH at 2 ti mes 
their physio lo gi cal con cen tra tion. In ad di tion, po-
ten tial in ter fe ri ng sub stan ces from se rum mat rix 
(he mog lo bin, trig lyce ri des and bi li ru bin) do not 
de te rio ra te ac cep tab le li mi ts of ± 10% diff e ren ce 
to the va lue of con trol spe ci men (68).
AMH Gen II as say, de ve lo ped by Bec kman Coul ter 
Com pa ny (Bec kman Coul ter Inc., Ca li for nia, USA), 
uses an ti bo dies de ve lo ped by Diag nos tic Syste ms 
La bo ra to ries (DSL Inc., Texas, USA) and has been 
stan dar di zed to the Im mu no te ch ca lib ra tion (Im-
mu no te ch a.s., Che ck Re pub lic) (67). The lowe st 
amou nt of AMH in a sam ple that can be de tec ted wi-
th 95% pro ba bi li ty is 0.56 pmol/L (0.08 ng/mL). Pas-
si ng-Bab lok reg res sion ana lysis has shown a good 
cor re la tion wi th the Im mu no te ch AMH ELISA (r = 
0.99; P < 0.001; y = 1.0x) (67). Yet, it has to be ta ken 
in to ac cou nt that la bo ra to ries im ple men ti ng Bec k-
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man Coul ter AMH Gen II as say shou ld expe ct an 
in crea se in AMH va lues of ap proxi ma te ly 40% (69).
As it is a re la ti ve ly new as say, a need exis ts for in te r-
la bo ra to ry com pa ri son in the fo rm of an exter nal 
qua li ty as su ran ce sche me (70). Even mo re, la bo ra to-
ries that ha ve im ple men ted AMH im mu noas say in a 
rou ti ne prac ti ce shou ld en ro ll in the exter nal pro fi -
cien cy tes ti ng prog ram. The la te st has re cen tly been 
es tab lis hed un der UK NEQAS sche me de si gn (71).
Con clu sion
Exten si ve in ves ti ga tion of cli ni cal sig ni fi  can ce of 
AMH se rum va lues un doub ted ly con fi r ms that it is 
not ju st a “ha nd of bio lo gic wat ch”. One may thi nk 
that the scien tis ts ha ve re sear ched all the con di tio-
ns when AMH ser ves as a bioc he mi cal mar ker of 
ma le and fe ma le physio lo gy and pa top hysio lo gy. 
Cer tain ly, we shou ld be awa re of an out stan di ng 
ro le of AMH in diff e re nt sta ges of hu man li fe. Per-
ha ps mo re pros pec ti ve lo ng te rm stu dies in heal-
thy po pu la tion are nee ded to eva lua te the re liab le 
re fe ren ce va lues ac cor di ng to ages, es pe cial ly in 
wo men wit hin the rep ro duc ti ve li fe span. This cou-
ld fa ci li ta te a cor re ct eva lua tion of ova rian re ser ve 
in in fer ti le sub jec ts, al low a mo re ac cu ra te pre dic-
tion of rep ro duc ti ve po ten tial and im pro ve coun-
se li ng in par ti cu lar ca ses.
Po ten tial con fl i ct of in te re st
No ne dec la red.
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An ti-Mülle rov hor mo n: je din stve ni bio ke mij ski mar ker raz vo ja go na da i plod-
nos ti
Sažetak
An ti-Mülle rov hor mon (AMH) je gli kop ro tein di mer ne gra đe iz sku pi ne tran sfor mi ra ju ćih β-fak to ra ras ta (TGF-β). Te melj na ulo ga AMH za poči nje 
ti je kom spol ne di fe ren ci ja ci je u os mom ges ta cij skom tjed nu, ka da dje lu je na reg re si ju Mülle ro vih ka na la u muš kog plo da. Izos ta ne li reg re sij ski 
uči nak AMH, iz Mülle ro vih se ka na la raz vi ja ma ter ni ca, ja jo vo di i gor nji di je lo vi va gi ne, od nos no žen ski unu tar nji rep ro duk tiv ni or ga ni. U dje ča-
ka, sin te za AMH se od vi ja u Ser to li je vim sta ni ca ma sje me ni ka, zna čaj nog je in ten zi ta ta do pu ber te ta, na kon če ga pos tup no opa da na os nov nu 
ra zi nu do kra ja ži vo ta muš kar ca. AMH slu ži kao bio ke mij ski bi ljeg za do ka zi va nje pri sut nos ti sje me ni ka, uko li ko ni su spuš te ni unu tar moš nji muš-
kog no vo ro đen če ta (krip tor hi zam). U že na, AMH se sin te ti zi ra u gra nu loz nim sta ni ca ma ma lih an tral nih fo li ku la u jaj ni ci ma. Ti je kom dje tinj stva 
kon cen tra ci ja AMH u se ru mu je nis ka ili nem jer lji va. In ten zi vi ra nje sin te ze u jaj ni ci ma s po čet kom pu ber te ta od ra ža va po če tak reg ru ti ra nja pri-
mor di jal nih fo li ku la. Ras tu ći fo li ku li proiz vo de AMH dok ne dos tig nu ve li či nu i sta dij ka da se iz dva ja do mi nan tni fo li kul, či ji je dalj nji raz voj ovi san 
o dje lo va nju fo li ku lo-sti mu li ra ju ćeg hor mo na (FSH). Se rum ske kon cen tra ci je AMH ti je kom rep ro duk tiv nog ži vo ta že ne idea lan su pa ra me ter u 
proc je ni ova rij ske re zer ve jaj nih sta ni ca (oo ci ta). Pred no st je AMH, u us po red bi s dru gim hor mo ni ma jaj ni ka, da pros ječ ne kon cen tra ci je u cir ku-
la ci ji ne os ci li ra ju zna čaj no ti je kom men strua cij skog cik lu sa. Po red to ga, kon cen tra ci je AMH u se ru mu po ka zu ju vi so ki stu panj ko re la ci je s bro jem 
an tral nih fo li ku la (AFC) ko ji se ul traz vuč no pra ti ti je kom fo li ku lar ne fa ze cik lu sa. Ka ko ti je kom rep ro duk tiv nog ži vo ta že ne opa da broj i kva li te ta 
oo ci ta, se rum ske kon cen tra ci je AMH pos tup no opa da ju, pos ta ju ći nem jer lji ve s nas tu pa njem me no pau ze. Ova je zna čaj ka AMH od oso bi tog in te-
re sa u že na ko je se zbog sma nje ne plod nos ti pod vr ga va ju pos tup ci ma me di cin ski pot po mog nu te op lod nje.
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ng/mL (pmol/L)* Range (5. – 95. percentile)**
<25 65 3.59 (25.63) 1.13–10.4 (8.02–74.20)
25 33 3.91 (27.92) 0.81–8.20 (5.78–58.55)
26 48 4.23 (30.20) 1.00–9.08 (7.14–64.83)
27 60 3.33 (23.78) 1.44–8.38 (10.28–59.69)
28 58 4.24 (30.27) 1.02–10.73 (7.28–76.61)
29 69 3.87 (27.63) 0.51–9.12 (3.64–65.12)
30 76 3.51 (25.06) 1.10–6.75 (7.85–48.20)
31 73 3.23 (23.06) 0.55–8.68 (3.93–61.98)
32 70 3.50 (24.99) 0.61–8.80 (5.78–62.83)
33 64 2.80 (19.99) 0.92–7.88 (6.57–56.26)
34 64 2.54 (18.14) 0.69–7.00 (4.93–49.98)
35 64 3.10 (22.13) 1.14–7.17 (8.14–51.19)
36 74 2.62 (18.71) 0.37–9.14 (2.64–65.26)
37 70 1.72 (12.28) 0.05–5.50 (0.36–39.27)
38 61 2.16 (15.42) 0.47–6.66 (3.36–47.55)
39 59 1.74 (12.42) 0.41–5.22 (2.92–37.27)
40 36 1.62 (11.57) 0.09–8.83 (0.64–59.26)
41 16 1.17 (8.35) 0.43–6.01 (3.07–42.91)
42 20 1.26 (8.99) 0.15–3.66 (1.07–26.13)
43 17 0.79 (5.64) 0.12–1.94 (0.86–13.85)
>43 8 0.88 (6.28) 0.01–3.84 (0.07–27.42)
All 1105 2.89 (20.63) 0.47–8.25 (3.36–58.91)
* Values in parenthesis are expressed in pmol/L (Conversion factor: ng/ml x 7.14 = pmol/l
** CI – Confi dence interval
TABLE 2. Basal serum AMH levels in presumably healthy women according to age distribution (38).
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